Pro Share Advisors LLC Generation Bio Co. Transaction History

Pro Share Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$3.65 - $6.9 $193 - $365	53 Added 0.52%	10,192 $38,000
Q2 2023 Aug 10, 2023	BUY	$3.5 - $5.67 $35,486 - $57,488	10,139 New	10,139 $55,000
Q4 2022 Feb 02, 2023	BUY	$3.66 - $6.77 $3,118 - $5,768	852 Added 8.31%	11,103 $43,000
Q3 2022 Nov 04, 2022	BUY	$4.68 - $8.34 $47,974 - $85,493	10,251 New	10,251 $54,000
Q2 2022 Aug 01, 2022	SELL	$4.87 - $9.41 $68,740 - $132,822	-14,115 Closed	0 $0

Q1 2022 May 10, 2022	SELL	$4.16 - $7.76 $14,322 - $26,717	-3,443 Reduced 19.61%	14,115 $103,000
Q4 2021 Feb 08, 2022	SELL	$5.99 - $24.97 $1,114 - $4,644	-186 Reduced 1.05%	17,558 $124,000
Q3 2021 Nov 12, 2021	SELL	$20.0 - $27.43 $75,960 - $104,179	-3,798 Reduced 17.63%	17,744 $445,000
Q2 2021 Aug 13, 2021	BUY	$24.34 - $38.34 $78,618 - $123,838	3,230 Added 17.64%	21,542 $579,000
Q1 2021 May 14, 2021	BUY	$24.74 - $40.2 $208,162 - $338,242	8,414 Added 85.01%	18,312 $521,000
Q4 2020 Feb 09, 2021	BUY	$21.68 - $51.61 $214,588 - $510,835	9,898 New	9,898 $281,000

49.5M

20.3K

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $138M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.